Device Assembly, Packaging & Logistics

Device Assembly, Packaging & Logistics
Product Description

Device platforms: autoinjector, accessorized prefilled syringe, and cartridge assembly, supporting APFS, Ypsomed, and SHL platforms, plus additional device and proprietary platforms [TK: confirm current platform list] 

Packaging: labeling, serialization, and aggregation across bulk, multi-unit, and single-unit configurations 

Sites: Cincinnati (six device assembly and packaging suites [TK: confirm current count]) and Blue Ash (device assembly and packaging capacity under construction) 

Storage: in-house and third-party ambient and cold-chain warehousing, down to -70°C at Cincinnati [TK: confirm publishable] 

Network: Cincinnati and Blue Ash, both inside Resilience’s North American network 

Resilience

  • Country/Region:
    United States
  • Founded:
    2020
  • On CPHI since:
    2023
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Analytical Services
Biopharmaceutical
Contract Manufacturer
Intermediates Manufacturer
Packaging & drug delivery
Pharmaceutical Company (innovator finished products)
Supply Chain
Technology
Specifications
  • Details
    Resilience’s device assembly, packaging, and logistics services take a filled, inspected drug product and prepare it to ship: assembled into its final device, labeled, serialized, packaged, and moved into storage for distribution. These steps run today at Cincinnati, with device assembly and packaging capacity under construction at Blue Ash. 

Resilience

  • Country/Region:
    United States
  • Founded:
    2020
  • On CPHI since:
    2023
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Analytical Services
Biopharmaceutical
Contract Manufacturer
Intermediates Manufacturer
Packaging & drug delivery
Pharmaceutical Company (innovator finished products)
Supply Chain
Technology

More Products from Resilience (4)

  • Large Molecule Biologics Development

    Product Large Molecule Biologics Development

    Modalities: monoclonal antibodies, Fab fragments, Fc fusion proteins, recombinant proteins, and ADC intermediates 

    Scale: pilot-scale single-use bioreactors from 3 L to 500 L for process development and characterization 

    Stage coverage: preclinical and early phase through la...
  • Drug Substance Manufacturing

    Product Drug Substance Manufacturing

    Modalities: monoclonal antibodies, recombinant proteins (including complex and non-cytotoxic conjugated), fusion proteins, enzymes, bispecifics, and plasma proteins 

    Scale: single-use bioreactors 3L to 500L (development) and 50L to 2,000L (manufacturing) 

    Stage coverage: pre...
  • Parenteral Drug Product Manufacturing

    Product Parenteral Drug Product Manufacturing

    Parenteral Formats: vials, accessorized prefilled syringes, autoinjectors, pen injectors, and cartridges 

    Formulation: parenteral aseptic liquid, including adjuvant, suspension, and other complex presentations 

    Finishing: 100% visual inspection, device assembly, packaging, s...
  • Sterile Fill/Finish

    Product Sterile Fill/Finish

    Formats: vials, pre-filled syringes, and cartridges 

    Fill technology: isolator- and RABS-based automated and semi-automated lines 

    Sites: Toronto and Cincinnati, both commercially licensed 

    Stage coverage: clinical and commercial, GMP and non-GMP 
    ...